Hepatic (Liver) Function Panel
80076
- 042 Human immunodeficiency virus (HIV) disease
- 070.0-070.9 Viral hepatitis
- 130.5 Hepatitis due to toxoplasmosis
- 151.0-150.9 Malignant neoplasm of stomach
- 152.0-152.9 Malignant neoplasm of small intestine, including duodenum
- 153.0.153.9 Malignant neoplasm of colon
- 154.0-154.8 Malignant neoplasm of rectum, rectosigmoid junction, and anus
- 155.0-155.2 Malignant neoplasm of liver and intrahepatic bile ducts
- 156.0-156.9 Malignant neoplasm of gallbladder and extrahepatic bile ducts
- 157.0-157.9 Malignant neoplasm of pancreas
- 162.0-162.9 Malignant neoplasm of trachea, bronchus, and lung
- 172.0-172.9 Malignant neoplasm of skin
- 174.0-174.9 Malignant neoplasm of female breast
- 175.0-175.9 Malignant neoplasm of male breast
- 197.7 Secondary malignant neoplasm of respiratory and digestive systems, liver, specified as secondary
- 277.4 Disorders of bilirubin excreation
- 571.0-571.9 Chronic liver disease cirrhosis
- 572.0-572.8 Liver abscess and sequelae of chronic liver disease
- 573.0-573.9 Other disorders of liver
- 574.00-574.91 Cholethiasis
- 575.0-575.9 Other disorders of gallbladder
- 576.0-576.9 Other disorders of biliary tract
- 782.4 Jaundice, unspecified, not of newborn
- 789.01 Abdominal pain, right upper quadrant
- 789.05 Abdominal pain, periumbilic
- 789.06 Abdominal pain, epigastric
- 789.1 Hepatomegaly
- 790.4 Nonspecific elevation of levels of transaminase or lactic acide deydrogenase (LDH)
- 790.5 Other nonspecific abnormal serum enzyme levels
- 794.8 Nonspecific abnormal results of function studies, liver
- 995.0 Other anaphylactic shock
- V42.7 Organ or Tissue replaced by transplant, liver
- V58.1 Encounter for other and unspecified procedures and aftercare, chemotherapy
- V58.69 Long-term (current) use of other medications
- V67.51 Following completed treatment with high-risk medications, not elsewhere classified
This policy has been duplicated from the most current Medicare National Coverage Determination or Local Medical Review Policy available at the time this booklet was printed in October 2005. Medicare will consider this test(s) medically reasonable and necessary only if the test(s) was performed for any of the diagnoses/conditions listed on this page. This information is subject to change without notice, and Aurora Diagnostics Clinical Services is not responsible for consequences that may result from using such information. Aurora Diagnostics Clinical Services is not indicating one code is more acceptable than another, and that selected codes should reflect the patients actual medical condition as noted in their medical record.
